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The cystic fibrosis transmembrane conductance regulator (CFTR) is transported to the plasma membrane from endoplasmic reticulum (ER)
through the Golgi. Crucial to these trafficking events is the role of not only the proteinous factors but also the membrane lipids. However, the
involvement of lipids, such as phospholipids, on the regulation of CFTR trafficking has been largely unexplored. Here, we show that the inhibition
of phospholipase D (PLD)-mediated phosphatidic acid (PA) formation by 1-butanol inhibited the maturation and export of CFTR from the ER.
Exogenously added PA reversed these effects. Moreover, knock down of PLD1 by small interfering RNA decreased the expression of mature
CFTR. Interestingly, sustaining the level of PA, by the addition of excess PA in the presence of PA phosphatase inhibitor, attenuated the transport
of CFTR from the Golgi to plasma membrane and the retrograde transport of ΔF508 CFTR to the cytoplasm, a necessary step for the ER-
associated degradation of ΔF508 CFTR. These results indicated that the metabolism of PA modulated the intracellular dynamics and trafficking of
CFTR.
© 2007 Elsevier B.V. All rights reserved.Keywords: Phosphatidic acid; Phospholipase D; CFTR; ΔF508 CFTR; Trafficking; Retrotranslocation1. Introduction
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a polytopic integral membrane protein that mediates
transepithelial chloride transport across epithelial cells in
airways, pancreas, intestines and sweat glands [1,2]. Mutations
in the CFTR gene, such asΔF508 CFTR, lead to the absence or
malfunction of a regulated Cl− channel in the apical membrane
of secretory epithelia, resulting in the clinical symptoms of
cystic fibrosis [3]. Previous reports indicated that the COPII-
dependent machinery is involved in the exit of wild-type CFTR
from the ER and that the machinery does not recognize ΔF508
CFTR, resulting in the ER retention of the mutant CFTR [4].
However, the mechanism of recognition by the COPII vesicles⁎ Corresponding author. Tel./fax: +81 96 371 4405.
E-mail address: hirokai@gpo.kumamoto-u.ac.jp (H. Kai).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.08.011and regulation of intracellular trafficking of wild-type CFTR
through the Golgi apparatus to the plasma membrane after ER
exit has not been fully understood.
Phosphatidic acid (PA) has been proposed to play a role in
membrane vesicular trafficking and signal transduction [5]. Due
to its regulatory role, the level of PA itself should also be tightly
regulated through synthesis and turnover. Phospholipase D
(PLD), which catalyzes the hydrolysis of phosphatidylcholine
(PC) to generate PA, is a key enzyme of PA synthesis [5] while
phosphatidate phosphatase (PAP) mediates the conversion of
PA to diacylglycerol (DAG) [6,7]. The ability of PLD to form
phosphatidyl alcohol instead of PA in the presence of primary
alcohols has been used in numerous studies to investigate the
role of PLD-mediated PA formation in certain cellular processes
[5]. Recent reports showed that PLD-mediated PA synthesis is
involved in the formation of COPII vesicles [8,9]. These studies
suggest that phospholipids including PA may have important
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However, the relationship between PA and the trafficking of
CFTR is largely unknown.
In the present study, we demonstrate that PLD-mediated PA
formation is required for the export of CFTR from the ER exit
site to the Golgi. Interestingly, we also found that sustaining PA
by addition of excess PA in the presence of PAP inhibitor
repressed the post-Golgi transport of CFTR to the plasma
membrane and the retrograde transport of ΔF508 CFTR to
cytoplasm. These results signify a role for PA in the intracellular
dynamics and trafficking of CFTR.
2. Materials and methods
2.1. Antibodies and reagents
The following antibodies were used in this study: mouse anti-CFTR
(C-terminus specific; Genzyme/Techne, Cambridge, MA); rabbit anti-calnexin
(CNX; C-terminus specific) and mouse anti-KDEL (anti-BiP) from Stressgen
Biotechnologies; mouse anti-GM130 and mouse anti-P230 (trans-Golgi) from
BD Biosciences; rabbit anti-COPII (anti-Sec23; Affinity BioReagents); mouse
anti-ubiquitinated proteins (AFFINITI); mouse anti-Vimentin (V9) and mouse
anti-HA from Santa Cruz Biotechnology, Inc.; rabbit anti-IκBα (Cell Signaling
Technology, Inc.); Alexa Flour 546 F(ab′)2 fragment of goat anti-mouse IgG
(H+L) and Alexa Flour 546 goat anti-Rabbit IgG (+) from Molecular Probes
(Eugene, OR).MG-132was fromCalbiochem (SanDiego, CA), and brefeldin A,
cycloheximide, chlorpromazine and DL-propranolol were from Sigma-Aldrich.
sn-Glycero-3-phosphate,1,2-dilauroyl, monosodium salt (dilauroyl PA) was
from Avanti Polar Lipids, Inc. (Alabaster, AL).
2.2. Cell culture and transfection
Baby hamster kidney (BHK) cells stably expressing green fluorescent protein
(GFP)-CFTR (CFTR-BHK) and GFP-ΔF508 CFTR (ΔF508-BHK), and
Chinese hamster ovary (CHO) cells stably expressing CFTR (CFTR-CHO)
and ΔF508 CFTR (ΔF508-CHO) were grown and maintained as described
previously [10]. To increase CFTR expression, cells were incubated with 1 mM
(CFTR- and ΔF508-BHK cells) or 2 mM (CFTR-, ΔF508-CHO cells) sodium
butyrate for 20–24 h before analysis. For Western blotting experiments, CFTR-
and ΔF508-CHO cells were grown on 6-well plates. For immunofluorescence
experiments, CFTR- and ΔF508-BHK cells were grown on glass-bottomed
culture dishes. Transfection was performed using TransIT-LT1 transfection
reagent (Mirus, Madison, WI). Subconfluent cells were transfected with 2 μg of
plasmid DNA (pCGN, pCGN-HA-hPLD1b, pCGN-HA-hPLD1b K898R).
2.3. Small interfering RNA (siRNA) preparation and transfection
Specific PLD1 siRNA was designed as described in [11]. We used the 21-
nucleotide (nt) sense strand (5-CUGGAAGAUUACUUGACAAdTdT, cod-
ing region 547–565 relative to the start codon) and the 21-nt antisense strand
(5-UUGUCAAGUAAUCUUCCAGdTdT) of Chinese hamster PLD1 mRNA
(GenBank accession no. U94995). siRNA duplexwas prepared by SigmaGenosys
siRNA Service. Transient transfection of siRNA at a concentration of 25 nM was
performed using TransIT-TKO (Mirus) as described by the manufacturer.
2.4. RT-PCR
Total RNA was extracted from CFTR-CHO cells transfected with Luciferase
(Luc) or PLD1 siRNA using TRIzol reagent (Invitrogen Life Technologies, UK)
according to themanufacturer's protocol. Contaminating genomicDNAwas removed
with RNase-free DNase I (Takara, Japan). RT-PCR was performed with Takara RT-
PCRkit (Takara) according to themanufacturer's instructions. The primers used in the
PCR are as follows: (hamster PLD1, forward) 5′-GCCTATGGAAGGTGGGAT-
GAC-3′; (hamster PLD1, reverse) 5′-GGAGTACCTGTCAATGAAATCAGC-3′;(β-actin, forward) 5′-TAAAACGCAGCTCAGTAACAGTCGG-3′; (β-actin,
reverse) 5′-TGCAATCCTGTGGCATCCATGAAAC-3′.
2.5. SDS-PAGE and Western blotting
Lysates from CFTR- and ΔF508-CHO cells were prepared and analyzed by
SDS-PAGE and Western blotting as described in [10].
2.6. Pulse-chase analysis and immunoprecipitation
Pulse-chase analysis and immunoprecipitation were carried out as described
previously [10].
2.7. Subcellular fractionation
Subcellular fractionation was performed using the ProteoExtract™,
subcellular Proteome Extraction Kit from Calbiochem (Nottingham) according
to the manufacturer's protocol. Immunoblotting with the following antibodies
against the indicated marker proteins was used: anti-IκBα for the cytosolic
fraction and anti-calnexin for the membrane fraction.
2.8. Immunocytochemical analysis and confocal laser scanning
microscopy
Cells were prepared for immunocytochemical analysis and visualized with a
confocal scanning microscope as described in [10]. For immunostaining with
anti-COPII (Sec23) antibodies, cells were permeabilized with 0.05% saponin in
PBS. Cells were immunostained with the indicated primary antibodies and
Alexa Fluor secondary antibodies (1:500 dilution).
2.9. PA rescue experiment
PA phospholipid liposomes were prepared as described previously [8].
PA rescue experiments were done as follows: for Western blotting, CFTR-
CHO cells were incubated at 37 °C in the presence of 1% 1-butanol for
18 h. Subsequently, the cells were incubated at 37 °C in medium containing 1%
1-butanol with or without 50 μM dilauroyl PA for 6 h. Then the cell lysates
(40 μg) were analyzed by Western blotting with anti-CFTR antibody. For
immunofluorescence, CFTR-BHK cells were treated with 5 μg/ml brefeldin A
(BFA) for 6 h followed by additional 30-min incubation in 100 μM dilauroyl PA
solution at 4 °C. Then the PA-containing medium was replaced with fresh
medium containing 100 μM 1,2-dilauroyl PA or 0.5% 1-butanol or both. The
cells were re-incubated for indicated times in the presence of 1 mM
cycloheximide. After incubation, cells were fixed with 3.7% paraformaldehyde.
3. Results
3.1. PLD-mediated PA formation is required for CFTR
maturation
To examine the involvement of PLD-mediated PA formation
on the maturation of CFTR, we first treated CFTR-CHO cells
with 1-butanol or ethanol which is known to inhibit PLD
activity. As shown in Fig. 1A, the level of mature CFTR (band
C) was decreased upon treatment with primary alcohols in a
dose-dependent manner but was unaffected by treatment with
tertiary-butanol, which does not inhibit PLD-mediated PA
synthesis [5]. We observed that the level of immature CFTR
(band B) was unchanged. Consistently, ΔF508 CFTR, which is
expressed only in immature form, was not changed by the
treatments (Fig. 1B). By pulse-chase analysis we found that
maturation of CFTR occurred in control and tertiary-butanol-
treated cells but not in those treated with 1-butanol during the
Fig. 1. The effect of PLD inhibition on CFTR maturation. (A) CFTR-CHO and (B) ΔF508 CFTR-CHO cells were untreated or treated with the indicated
alcohol for 24 h. Cell lysates were analyzed by Western blotting with anti-CFTR and anti-calnexin (CNX; used as loading control) antibodies. (C) Radiolabeled
wild-type CFTR was immunoprecipitated from CFTR-CHO cell lysates after the indicated chase period in the absence (control) or presence of 1-butanol or
tert-butanol, and analyzed by SDS-PAGE. Graph shows the quantification of mature CFTR (band C) expressed as percentage of the total material present
at t=0. (D) CFTR-CHO cells were transfected with pCGN (control) or pCGN-HA-hPLD1b K898R. Thirty-six hours post-transfection, the cell lysates were
analyzed by Western blotting with anti-CFTR,-HA and-CNX (loading control) antibodies. Right panel shows the percent of mature CFTR (band C) as
quantified by Image Gauge software. Mean value±S.E.M. (n=3). Data were evaluated for statistical difference by analysis of t test. ⁎Pb0.05. (E) CFTR-CHO
cells were transfected with Luc siRNA (control siRNA) or PLD1 siRNA. Forty-eight hours post-transfection, the cell lysates were analyzed by Western blotting
with anti-CFTR, and-CNX (loading control) antibodies. Right panel shows the percent of mature CFTR (band C) as quantified by Image Gauge software. Mean
value±S.E.M. (n=3). Data were evaluated for statistical difference by analysis of t test. ⁎⁎⁎Pb0.005. (Lower panel) To confirm the effect of PLD1 siRNA,
total RNA extracted from CFTR-CHO cells transfected with Luc or PLD1 siRNA was analyzed by semi-quantitative RT-PCR. β-Actin was used as internal
control.
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Fig. 2. PA rescues the 1-butanol-induced suppression of maturation and transport of CFTR. (A) BHK cells stably expressing GFP-CFTR (CFTR-BHK) were treated
with BFA for 6 h. After treatment, cells were incubated in medium containing 1 mM cycloheximide (CHX) for 60 min with or without 0.5% 1-butanol or tertiary-
butanol. After incubation, (a) cells were fixed or (b) 1-butanol-treated cells were immunostained with anti-Sec23 antibody and analyzed by confocal microscopy.
(B) CFTR-CHO cells were incubated with 1% 1-butanol for 18 h. Subsequently, cells were incubated for additional 6 h in normal medium (lane 2) or medium
containing the indicated reagents. Lysates were analyzed byWestern blotting. Bar graphs show the quantification of mature CFTR (band C) expressed as percentage of
band C in the control (vector). Mean value±S.E.M. (n=3). ⁎Pb0.05, determined by t test. (C) CFTR-BHK cells were treated with BFA as above. BFAwas removed
and cells were incubated in serum-free medium containing 100 μM dilauroyl PA at 4 °C for 30 min. Medium was replaced with serum-free medium containing the
indicated reagents and 1 mM CHX. Cells were re-incubated for the indicated period, then were fixed and analyzed. Scale bars, 20 μm
156 Y. Hashimoto et al. / Biochimica et Biophysica Acta 1783 (2008) 153–162chase period (Fig. 1C), indicating that the decrease of mature
CFTR induced by 1-butanol was due to the inhibition of CFTR
maturation.To determine the specific role of PLD and which PLD
isoform is involved, we transfected a catalytically inactive
mutant of hPLD1, hPLD1b K898R [12], into CFTR-CHO cells.
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(Fig. 1D). In contrast, mPLD2 K758R overexpression, a
catalytically inactive mutant of PLD2, did not affect the CFTR
expression (data not shown). These results indicate that PLD1
but not PLD2 is important for the maturation of CFTR.
To confirm the involvement of PLD1 onCFTRmaturation, we
knocked down the PLD1 gene by small interfering RNA
(siRNA). As shown in Fig. 1E, transfection of PLD1 siRNA in
CFTR-CHO cells decreased the expression of mature CFTR
(bandC) comparedwith that in cells transfectedwith the unrelated
Luc siRNA. Taken together, these data suggest that PLD-
mediated PA formation is necessary for maturation of CFTR.
3.2. PLD-mediated PA formation is required for export of
CFTR from the ER
Because CFTR maturation occurs after ER export, we
examined the effect of PLD inhibition on the trafficking of
CFTR. First, to observe the time-dependent transport of CFTR
from the ER, the cells were treated with brefeldin A (BFA),
which inhibits the ER-to-Golgi pathway. Subsequent removal of
BFA (Supplementary Fig. 1A, 0–90 min) allowed CFTR to
traverse through the secretory pathway starting from the ER to
the ER exit site, to the Golgi (Supplementary Fig. 1B(a), (b), (c),
respectively), then to the plasmamembrane (Supplementary Fig.
1A, 90 min). These results indicated that the technique using
BFA was useful for the time-lapse imaging of the intracellular
trafficking of CFTR from the ER. We next determined the effect
of 1-butanol treatment on these events. In the control and
tertiary-butanol-treated cells, CFTR reached the Golgi 60 min
after BFA removal (Fig. 2A(a)). However, in 1-butanol-treated
cells, CFTR was retained in the ER exit site, co-localizing with
Sec23 60 min after BFA washout (Fig. 2A(b)). Collectively,
these data indicate that the inhibition of PLD-mediated PA
formation blocked the export of CFTR from the ER, thus
inhibiting its maturation.
To confirm the role of PA in CFTRmaturation and ER export,
we exogenously added PA to 1-butanol-treated cells. Contin-
uous treatment of cells with 1-butanol markedly reduced the
expression of mature CFTR (band C; Fig. 2B, lane 3), but the
effect of 1-butanol was reversible because its removal abrogated
the inhibition of CFTR maturation (lane 2). Interestingly,
addition of PA attenuated the effect of 1-butanol (lane 4).
Furthermore, the exogenously added PA also rescued the
trafficking defect of CFTR at the ER exit site (Fig. 2C). These
results strongly indicate that PA is an important determinant for
CFTR maturation and export from the ER.
3.3. Inhibition of PA phosphatase represses the post-Golgi
transport of CFTR
We next examined the effect of inhibiting PA conversion to
DAG on the trafficking of CFTR by utilizing chlorpromazine
(CPZ) and propranolol (PROP), which are potent inhibitors of
PAP [13,14]. Treatment ofΔF508 CFTR-BHK cells with CPZ or
PROP did not alter the localization of ΔF508 CFTR (Fig. 3A,
lower panels), consistent with our results that PA addition doesnot impact on the maturation and cannot rescue the ER retention
ofΔF508 CFTR (Supplementary Fig. 2). Surprisingly, wild-type
CFTR accumulated in the juxta-nuclear region in CPZ- or PROP-
treated cells (Fig. 3A, upper panels) and co-localized with Golgi
markers P230 and GM130 (Fig. 3B). This result was confirmed
by time-lapse imaging using BFA. In the control cells, CFTRwas
transported to the plasma membrane from the Golgi but in
100 μM CPZ-treated cells, CFTR was largely retained in the
Golgi 90 min after removal of BFA (Fig. 3C). The treatment with
20 μM CPZ allowed CFTR to shift to the cell surface indicating
that low-dose CPZmight not be sufficient tomaintain a high level
of PA in the cells (Fig. 3C; 20 μM CPZ). Similarly, the presence
of excess PA alone still enabled a fraction of CFTR to translocate
to the plasma membrane (Fig. 3C; 300 μM PA), most probably
due to the conversion of PA to DAG by PAP. However, the
addition of excess PA in the presence of low-dose CPZ effectively
suppressed the plasma membrane translocation of CFTR (Fig.
3C; CPZ, PA). These data imply that sustaining PA by CPZ
interfered with the transport of CFTR from the Golgi.
3.4. Inhibition of PA phosphatase attenuates the
retrotranslocation of ΔF508 CFTR
We next investigated the effect of PAP inhibitors on the
expression of wild-type and ΔF508 CFTR. Interestingly,
treatment of CFTR- or ΔF508 CFTR-CHO cells with CPZ or
PROP induced the appearance, in a dose-dependent (Fig. 4A, B)
and time-dependent manner (Fig. 4C, upper panel) of high
molecular weight (HMW) complex, which could be the
aggregated polyubiquitinated forms. The effect of PAP inhibitors
was more obvious on ΔF508 CFTR. Furthermore, similar ex-
pression pattern of ΔF508 CFTR was observed when cells were
treated with the proteasome inhibitor, MG132 (Fig. 4C, lower
panel) [10]. Considering thatΔF508 CFTR is a substrate for ER-
associated degradation (ERAD) [15,16], these results imply that
sustained PA might affect the ERAD pathway. We then inves-
tigated the relationship of PAP inhibitors and proteasomal
degradation. It has been reported that inhibition of proteasomal
degradation leads tomisfolded CFTR accumulation in the cytosol
and formation of aggresomes, which consist of ubiquitinated
proteins and are surrounded by vimentin cages [17,18]. We
examined whether these structures were observed upon PAP
inhibitor treatment. Confocal analysis revealed that in MG132-
treated cells, the ΔF508 CFTR co-localized with the aggresome
markers, ubiquitinated proteins and vimentin but not with BiP,
indicating that the aggregatedΔF508 CFTR exists outside of ER
(Fig. 4D, +MG132). In CPZ-treated cells, however, ΔF508
CFTR co-localized with BiP but not with ubiquitinated proteins.
Furthermore, vimentin did not condense but remained dispersed
in the cytoplasm as opposed to that observed in MG132-treated
cells. These results suggest thatΔF508 CFTR was retained in the
ER and that aggresomes did not form upon PAP inhibitor
treatment. To clarify whether or not CPZ induces formation of
polyubiquitinatedΔF508 CFTR, the immunoprecipitatedΔF508
CFTR was probed with anti-ubiquitinated protein antibody. In
cells treated with CPZ, we did not detect the accumulation of
polyubiquitinated ΔF508 CFTR, unlike in MG132-treated cells
Fig. 3. PA phosphatase inhibitors repress the post-Golgi transport of CFTR. (A) CFTR-BHK andΔF508 CFTR-BHK cells were treated with chlorpromazine (CPZ) or
propranolol (PROP) for 6 h. (B) CFTR-BHK cells were treated with CPZ for 6 h, fixed and immunostained with anti-P230 and anti-GM130 antibodies. (C) CFTR-
BHK cells were treated with BFA for 6 h. After BFA removal, cells were incubated in mediumwithout or with 20 μMCPZ, 100 μMCPZ, 300 μMdilauroyl PA or both
CPZ (20 μM) and dilauroyl PA for the indicated period in the presence of 1 mM CHX. Then cells were fixed and analyzed. Scale bars, 20 μm.
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recognized by anti-CFTR antibody, this species might be the non-
ubiquitinated form of ΔF508 CFTR.
Based on our observations that in CPZ-treated cells, ΔF508
CFTR was retained in the ER and accumulated in non-
polyubiquitinated form, we checked the possibility that inhibiting
PA conversion to DAG might prevent the retrotranslocation ofFig. 4. PA phosphatase inhibitors repress the retrotranslocation of ΔF508 CFTR. (A
panels) or propranolol (lower panels) for 6 h. (C)ΔF508 CFTR-CHO cells were treat
lysates were analyzed by Western blotting with anti-CFTR and anti-CNX (loading con
then cells were fixed and immunostained with anti-ubiquitinated proteins, – vimenti
with CPZ or MG132 for 6 h were lysed in RIPA buffer and cell lysates were immunop
analyzed by Western blotting with the indicated antibodies. (F) ΔF508 CFTR-CHO c
Each cell fraction was immunoblotted with anti-IκBα (for cytosolic fraction) and anti
Immunoprecipitants were analyzed byWestern blotting with the indicated antibodies.
to cellular fractionation. Cytosolic fractions were immunoprecipitated with anti-CFT
ubiquitinated proteins antibody. (H)ΔF508 CFTR-CHO cells treated for 6 h with low
were subjected to cellular fractionation. Each cell fraction was immunoblotted wit
immunoprecipitated with anti-CFTR antibody. Immunoprecipitants were analyzed bΔF508 CFTR to the cytosol. We determined by cell fractionation
of MG132-treated ΔF508 CFTR-CHO cells that polyubiquiti-
natedΔF508 CFTRwas present in the cytosol and ERmembrane
fractions (Fig. 4F, upper panel, lanes 3 and 6) while immature
ΔF508 CFTR (band B) was present in the membrane fraction
(Fig. 4F, lower panel, lane 6). These data indicate that
ubiquitination of ΔF508 CFTR firstly occurred on the ER) CFTR-CHO and (B) ΔF508 CFTR-CHO cells were treated with CPZ (upper
ed with CPZ (upper panel) or MG132 (lower panel) for the indicated period. Cell
trol) antibodies. (D) CFTR-BHK cells were treated with MG132 or CPZ for 4 h,
n and – BiP antibodies. Scale bars, 20 μm. (E) ΔF508 CFTR-CHO cells treated
recipitated with anti-CFTR or control IgG antibodies. Immunoprecipitants were
ells treated with CPZ or MG132 for 6 h were subjected to cellular fractionation.
-CNX (for membrane fraction) or immunoprecipitated with anti-CFTR antibody.
(G)ΔF508 CFTR-CHO cells treated with CPZ or MG132 or both were subjected
R antibody. Immunoprecipitants were analyzed by Western blotting with anti-
-dose CPZ (20 μM), 300 μMdilauroyl PA, both CPZ and PA or MG-132 (10 μM)
h anti-IκBα (for cytosolic fraction) and anti-CNX (for membrane fraction) or
y Western blotting with the indicated antibodies.
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Fig. 4 (continued).
160 Y. Hashimoto et al. / Biochimica et Biophysica Acta 1783 (2008) 153–162membrane. Subsequently, polyubiquitinated ΔF508 CFTR was
retrotranslocated to the cytosol and degraded by proteasome. In
CPZ-treated cells, however, polyubiquitinatedΔF508 CFTRwas
absent in the cytosol fraction (Fig. 4F, upper panel, lane 2)
whereas immature ΔF508 CFTR (band B) was highly accumu-
lated in the membrane fraction (Fig. 4F, lower panel, lane 5),
indicating that CPZ attenuated the retrotranslocation of ΔF508
CFTR. To check whether CPZ could abrogate the effect of
MG132, we performed co-treatment with MG132 and CPZ of
ΔF508 CFTR-CHO cells, followed by cell fractionation. In
MG132+CPZ-treated cells, cystosolic polyubiquitinated ΔF508
CFTRwas dramatically decreased comparedwith that inMG132-
treated cells (Fig. 4G, lanes 3 and 4). To confirm the effect ofinhibiting PA conversion on the retrotranslocation of ΔF508
CFTR, we performed cellular fractionation of cells treated with
low-dose CPZ, excess PA, or excess PA and low-dose CPZ.
Unlike in MG132-treated cells, polyubiquitinated CFTR was not
expressed in the cytosol and ER membrane in CPZ-, PA- or CPZ
and PA-treated CFTR-CHO cells (Fig. 4H, upper panel),
consistent with the results above. However, immature ΔF508
CFTR (band B) accumulated in the membrane but not in the
cytosol fraction in cells treatedwith low-doseCPZ or PA (Fig. 4H,
lower panel, lanes 7 and 8, respectively). Moreover, the co-
treatment with PA and low-dose CPZ induced greater accumu-
lation of immature ΔF508 CFTR in the ER membrane (Fig. 4H,
lower panel, lane 9). Taken together, these results suggested that
161Y. Hashimoto et al. / Biochimica et Biophysica Acta 1783 (2008) 153–162inhibiting the conversion of PA by CPZ represses the retro-
translocation of ΔF508 CFTR.
4. Discussion
We show here that PLD-mediated PA formation is required
for CFTR transport from the ER exit site to the Golgi (Figs. 1,
2). Although this is unlikely a CFTR-specific mechanism [8],
the present study firstly demonstrates the possible involvement
of PA in the trafficking of CFTR. Interestingly, the
requirement of PA might be transient and limited to specific
membrane vesicular trafficking events because sustaining the
level of PA by inhibiting its conversion to DAG did not
interfere with the ER-to-Golgi transport, but it disrupted the
post-Golgi transport of CFTR (Fig. 3). Numerous studies have
investigated the effects of PA on vesicular trafficking but most
of these focused on PLD-mediated synthesis of PA. In
contrast, not much attention has been given to the effects of
PA turnover on trafficking event. Since the PA level is tightly
regulated, we postulated that the metabolism of PA is an
important factor in the regulation of trafficking. As what we
have demonstrated here (Fig. 3), the PA level must necessarily
be well regulated particularly in the Golgi membrane to
maintain the function of Golgi apparatus for proper post-Golgi
transport [19].
Inhibiting PA conversion to DAG also suppressed the
retrotranslocation of ΔF508 CFTR (Fig. 4). However, this
phenomenon was not observed upon the inhibition of PA
formation by 1-butanol (Fig. 1B), implying that PLD-mediated
PA formation is not required for the retrotranslocation of
CFTR for ERAD. Considering that PLD-mediated PA
synthesis is necessary for COPII coat assembly [8,9], it is
probable that the retrotranslocation machinery is independent
of the COPII machinery. This is supported by the study done
previously [4].
CPZ treatment led to the appearance of lower molecular
weight form ofCFTR and the accumulation of ubiquitin-negative
HMW complex in the membrane fraction (Fig. 4), which may be
the deglycosylated form of ΔF508 CFTR and aggregates of
deglycosylated ΔF508 CFTR, respectively. However, treatment
of these lysates with endoglycosidase H (EndoH) had shifted the
lower molecular weight band (data not shown), indicating that
these species were not deglycosylated ΔF508 CFTR and its
aggregates, but what exactly is the observed non-ubiquitinated
HMW complex in CPZ-treated cells remains unknown.
Although the accumulation of immature ΔF508 CFTR in the
membrane fraction in the presence of CPZ and excess PA (Fig.
4H) highly suggested the inhibition of the retrotranslocation of
ΔF508 CFTR, we cannot exclude the possibility that dysregu-
lated PA metabolism could interfere with the ubiquitination of
ΔF508 CFTR, leading to the non-recognition of ΔF508 CFTR
by the retrotranslocation machinery.
Many mechanistic questions remain regarding the process of
retrotranslocation including the role of membrane phospholipid
composition and howmulti-membrane spanning proteins such as
CFTR are retrotranslocated to the cytosol from the ER
membrane. It is likely that not only the recruitment of variousproteins but also the metabolism of some membrane lipids, such
as PA conversion to DAG, is necessary during retrotranslocation.
Sustained PA level at the ER membrane could alter the
composition of lipid bilayers and could disrupt the interaction
of retrotranslocation-related factors with ER membranes, such as
the factors p97 andDerlin-1, which recognizes non-ubiquitinated
CFTR [20–24], resulting in the attenuation of the retrotransloca-
tion efficiency. Further studies are necessary to elucidate the
involvement of ER membrane phospholipids and retrotransloca-
tion-related factors in the retrotranslocation of CFTR for ERAD.
Our data firstly demonstrate the involvement of PA metabo-
lism in the process of retrotranslocation of ERAD substrates such
as ΔF508 CFTR. Furthermore, our findings propose that sus-
tained PA induces a negative effect on the intracellular
trafficking, suggesting that PA conversion is an important step
on the regulation of PA function. In conclusion, our findings
indicate that PA formation and turnover may regulate various
steps in the intracellular trafficking and ERAD of CFTR.
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